Navigation Links
Oxford Performance Materials Introduces OXPEKK PermettaTM High Performance Polymer Films

High performance thermoplastic OXPEKK® PermettaTM films now available from OPM. Ideal for high temperature applications within electronic, semiconductor and aerospace markets.

Enfield, CT, USA (PRWEB) June 15, 2009 -- Oxford Performance Materials (OPM), part the Arkema Group, France's leading chemicals producer, has introduced OXPEKK® PermettaTM films. These new products have a wide variety of uses in aerospace, industrial, electronic and medical markets. OXPEKK® PermettaTM films offer very high thermal performance, excellent adhesion behavior, excellent abrasion resistance, along with highly selectable electrical properties. In addition, OXPEKK® PermettaTM is inherently flame retardant UL94 V-0 rated, meets OSU 65/65 and is available in medical implant grades supported by extensive ISO 10993 biocompatibility testing. Specific grades are available for long term medical implants. OXPEKK® PermettaTM also is a green product, as it enjoys the benefit of producing no volatile organic compounds when processed.

OXPEKK® PermettaTM is made from the firm's polyetherketoneketone polymer which is produced in an amorphous and crystalline form. The initial offering will include films with a width up to 393 mm and thickness from 25 to 600 microns.

Typical applications include use as an adhesive layer for composites, membrane systems, dielectric film for flex circuits and for metal composite hybrids. OXPEKK® PermettaTM is a suitable adhesive for carbon, glass, aramid, ceramic, PBO and metallic materials. As a true thermoplastic, OXPEKK® PermettaTM can be processed by nip-roll and compression molding. Target applications include aerostructures, safety protective composites, electronics, as well as soundproofing and dampening.

The OXPEKK® PermettaTM products are available in the Americas directly from OPM. In Europe the product will be made available from Velox (, the firm's current distributor of granules. In Asia the products will be made available directly from Arkema Japan (

About OPM
Founded in March 2000, OPM has rapidly become an industry leader in the ultra-high performance thermoplastic polymers market. The firm's versatile OXPEKK® polymers are currently being used in medical, space and defense, semiconductor and industrial markets worldwide. OPM is ISO 9001:2000 and ISO 13485:2003 registered. For additional information, please visit In February 2009 OPM was acquired by Arkema.

About Arkema
A global chemical company and France's leading chemicals producer, Arkema consists of three strategically related businesses: Vinyl Products, Industrial Chemicals, and Performance Products. Arkema reported sales of 5.7 billion euros in 2007. Arkema has 15,200 employees across over 40 countries and six research centers located in France, the United States and Japan. With internationally recognized brands, Arkema holds leadership positions in its principal markets.

# # #

Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. TED Conferences Announces 25 TED Fellows for TEDGlobal in Oxford
2. The Court Supports Bavarian Nordics Decision to Start Patent Infringement Case Against Oxford BioMedica
3. Bavarian Nordics Case Against Oxford BioMedica
4. New Dual Wavelength X-ray Diffractometer From Oxford Diffraction, Now a Part of Varian, Inc., Allows Increased Throughput for Challenging Single Crystal Analyses
5. Oxford Finance Corporation and ATEL Ventures, Inc. Provide $7.5 Million Venture Loan to AxoGen, Inc.
6. Oxford Finance Corporation and Comerica Bank Provide $15 Million Loan Facility to VisualSonics Inc.
7. Sigma-Aldrich, Oxford BioMedica and Open Biosystems Settle Patent Dispute Over Use of LentiVector Technology in Research Reagents
8. Oxford Genome Sciences and Amgen to Jointly Discover Novel Therapeutic Antibodies in Cancer
9. Oxford Finance Corporation and GE Healthcare Financial Services Reaffirm Commitment to Biotech Sector in Europe
10. Oxford Genome Sciences Appoints Chris Hibberd to its Board of Directors
11. Sigma-Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute
Post Your Comments:
Related Image:
Oxford Performance Materials Introduces OXPEKK PermettaTM High Performance Polymer Films
(Date:11/24/2015)... ... November 24, 2015 , ... The Academy of Model Aeronautics (AMA), ... MultiGP, also known as Multirotor Grand Prix, to represent the First–Person View (FPV) racing ... AMA members have embraced this type of racing and several new model aviation pilots ...
(Date:11/24/2015)... , November 24, 2015 ... recent market research report released by Transparency Market Research, ... expand at a CAGR of 17.5% during the period ... Testing Market - Global Industry Analysis, Size, Volume, Share, ... global non-invasive prenatal testing market to reach a valuation ...
(Date:11/24/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: ... 11,000 post-share consolidation (or 1,100,000 pre-share consolidation) Series ... Warrants") subject to the previously disclosed November 1, ... which will result in the issuance of 365,518 ... issuance of such shares, there will be approximately ...
(Date:11/24/2015)... , ... November 24, 2015 , ... ... the environment are paramount. Insertion points for in-line sensors can represent a weak ... the InTrac 781/784 series of retractable sensor housings , which are designed ...
Breaking Biology Technology:
(Date:11/12/2015)... , Nov. 12, 2015  Arxspan has ... of MIT and Harvard for use of its ... information management tools. The partnership will support the ... biological and chemical research information internally and with ... be used for managing the Institute,s electronic laboratory ...
(Date:11/10/2015)... YORK , Nov. 10, 2015 ... to behavioral biometrics that helps to identify and ... fraud. Signature is considered as the secure and ... the identification of a particular individual because each ... more accurate results especially when dynamic signature of ...
(Date:11/2/2015)...  SRI International has been awarded a contract of ... to the National Cancer Institute (NCI) PREVENT Cancer Program ... modern testing and support facilities, and analytical instrumentation to ... studies to evaluate potential cancer prevention drugs. ... Drug Development Program is an NCI-supported pipeline to bring ...
Breaking Biology News(10 mins):